659
Participants
Start Date
July 31, 2007
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
AZD3480
3 oral doses
Donepezil
Research Site, Graz
Research Site, Innsbruck
Research Site, Vienna
Research Site, Linz
Research Site, Aalst
Research Site, Antwerp
Research Site, Hasselt
Research Site, Leuven
Research Site, Sint-Truiden
Research Site, Pleven
Research Site, Plovdiv
Research Site, Rousse
Research Site, Sofia
Research Site, Varna
Research Site, Calgary
Research Site, Edmonton
Research Site, Winnipeg
Research Site, Ottawa
Research Site, Peterborough
Research Site, Toronto
Research Site, Greenfield Park
Research Site, Québec
Research Site, Verdun
Research Site, Regina
Research Site, Brno
Research Site, Havlíčkův Brod
Research Site, Hradec Králové
Research Site, Kladno
Research Site, Litoměřice
Research Site, Nový Jičín
Research Site, Olomouc
Research Site, Ostrava - Poruba
Research Site, Prague
Research Site, Prostějov
Research Site, Bad Saarow
Research Site, Berlin
Research Site, Dresden
Research Site, Freiburg im Breisgau
Research Site, Heidelberg
Research Site, Kiel-kronshagen
Research Site, Leipzig
Research Site, Lübeck
Research Site, Magdeburg
Research Site, Mannheim
Research Site, München
Research Site, Nuremberg
Research Site, Piteşti
Research Site, Târgu Mureş
Research Site, Bucharest
Research Site, Iași
Research Site, Sibiu
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Smolensk
Research Site, Palma de Mallorca
Research Site, Salamanca
Research Site, Barcelona
Research Site, Hospitalet de Llobregat(barcel
Research Site, Salt (girona)
Research Site, Terrassa
Research Site, Madrid
Research Site, Castellon
Research Site, Baracaldo (vizcaya)
Research Site, Uckfield
Research Site, Southampton
Research Site, Blackpool
Research Site, Bradford
Research Site, London
Research Site, Peterborough
Research Site, Swindon
Lead Sponsor
AstraZeneca
INDUSTRY